Jill P. Smith All publications ( 45 ) Smith JP. Stock H. Bingaman S. Mauger D. Rogosnitzky M. Zagon IS. Low-dose naltrexone therapy improves active Crohn's disease. 2007 Apr. Am J Gastroenterol. 102(4):820-8. National Center for Research Resources Zagon IS. Jaglowski JR. Verderame MF. Smith JP. Leure-Dupree AE. McLaughlin PJ. Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma. 2005 Nov. Cancer Chemother Pharmacol. 56(5):510-20. Smith JP. Stanley WB. Verderame MF. Zagon IS. The functional significance of the cholecystokinin-C (CCK-C) receptor in human pancreatic cancer. 2004 Nov. Pancreas. 29(4):271-7. National Cancer Institute Smith JP. Verderame MF. Ballard EN. Zagon IS. Functional significance of gastrin gene expression in human cancer cells. 2004 Mar 15. Regul Pept. 117(3):167-73. National Cancer Institute Smith JP. Conter RL. Bingaman SI. Harvey HA. Mauger DT. Ahmad M. Demers LM. Stanley WB. McLaughlin PJ. Zagon IS. Treatment of advanced pancreatic cancer with opioid growth factor: phase I. 2004 Mar. Anticancer Drugs. 15(3):203-9. National Cancer Institute National Center for Research Resources Smith JP. Riley TR. Bingaman S. Mauger DT. Amantadine therapy for chronic hepatitis C: a dose escalation study. 2004 Jun. Am J Gastroenterol. 99(6):1099-104. National Center for Research Resources National Institute of Allergy and Infectious Diseases Smith JP. Riley TR. Devenyi A. Bingaman SI. Kunselman A. Amantadine therapy for chronic hepatitis C. 2004 Jun. J Gen Intern Med. 19(6):662-8. National Institute of Allergy and Infectious Diseases Smith JP. Verderame MF. McLaughlin P. Martenis M. Ballard E. Zagon IS. Characterization of the CCK-C (cancer) receptor in human pancreatic cancer. 2002 Dec. Int J Mol Med. 10(6):689-94. National Cancer Institute Zagon IS. Smith JP. Conter R. McLaughlin PJ. Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma. 2000 Jan. Int J Mol Med. 5(1):77-84. National Cancer Institute Smith JP. Conter RL. Demers TM. McLaughlin PJ. Zagon IS. Elevated levels of opioid growth factor in the plasma of patients with pancreatic cancer. 2000 Aug. Pancreas. 21(2):158-64. National Cancer Institute Holliman CJ. Green GB. VanRooyen MJ. Clem K. Smith JP. Ankel FK. Hirshon JM. Thomas T. Perez N. Davis M. Wolf LR. Proposed curriculum for an "observational" international emergency medicine fellowship program. 2000 Apr. Acad Emerg Med. 7(4):359-64. Riley TR. Smith JP. Preventive care in chronic liver disease. 1999 Nov. J Gen Intern Med. 14(11):699-704. Zagon IS. Smith JP. McLaughlin PJ. Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. 1999 Mar. Int J Oncol. 14(3):577-84. National Cancer Institute Smith JP. Verderame MF. Zagon IS. Antisense oligonucleotides to gastrin inhibit growth of human pancreatic cancer. 1999 Jan 8. Cancer Lett. 135(1):107-12. National Cancer Institute Smith JP. Kanekal S. Patawaran MB. Chen JY. Jones RE. Orenberg EK. Yu NY. Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts. 1999. Cancer Chemother Pharmacol. 44(4):267-74. Riley TR. Smith JP. Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series. 1998 Sep. Am J Gastroenterol. 93(9):1563-5. Smith JP. Hamory MW. Verderame MF. Zagon IS. Quantitative analysis of gastrin mRNA and peptide in normal and cancerous human pancreas. 1998 Sep. Int J Mol Med. 2(3):309-315. Smith JP. Shih AH. Wotring MG. McLaughlin PJ. Zagon IS. Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma. 1998 Feb. Int J Oncol. 12(2):411-9. National Cancer Institute Zagon IS. Hytrek SD. Smith JP. McLaughlin PJ. Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice. 1997 Jan 30. Cancer Lett. 112(2):167-75. National Cancer Institute National Heart, Lung, and Blood Institute National Institute of Neurological Disorders and Stroke Smith JP. Treatment of chronic hepatitis C with amantadine. 1997 Aug. Dig Dis Sci. 42(8):1681-7. Smith JP. Stock EA. Wotring MG. McLaughlin PJ. Zagon IS. Characterization of the CCK-B/gastrin-like receptor in human colon cancer. 1996 Sep. Am J Physiol. 271(3 Pt 2):R797-805. National Cancer Institute Zagon IS. Hytrek SD. Lang CM. Smith JP. McGarrity TJ. Wu Y. McLaughlin PJ. Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer. 1996 Sep. Am J Physiol. 271(3 Pt 2):R780-6. National Heart, Lung, and Blood Institute National Institute of Neurological Disorders and Stroke Smith JP. Shih A. Wu Y. McLaughlin PJ. Zagon IS. Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion. 1996 May. Am J Physiol. 270(5 Pt 2):R1078-84. National Cancer Institute Hytrek SD. Smith JP. McGarrity TJ. McLaughlin PJ. Lang CM. Zagon IS. Identification and characterization of zeta-opioid receptor in human colon cancer. 1996 Jul. Am J Physiol. 271(1 Pt 2):R115-21. National Heart, Lung, and Blood Institute National Institute of Neurological Disorders and Stroke National Center for Research Resources Smith JP. Fantaskey AP. Liu G. Zagon IS. Identification of gastrin as a growth peptide in human pancreatic cancer. 1995 Jan. Am J Physiol. 268(1 Pt 2):R135-41. National Cancer Institute Smith JP. Stock E. Orenberg EK. Yu NY. Kanekal S. Brown DM. Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of human pancreatic cancer xenografts. 1995 Dec. Anticancer Drugs. 6(6):717-26. Swift IR. Smith JP. Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer. 1994 May. Dig Dis Sci. 39(5):1007-13. National Cancer Institute Smith JP. Liu G. Soundararajan V. McLaughlin PJ. Zagon IS. Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. 1994 Jan. Am J Physiol. 266(1 Pt 2):R277-83. National Cancer Institute Smith JP. Doll D. Croitoru R. Thornton C. Perry MC. Octreotide has no effect on advanced colon cancer. 1994 Apr. J Clin Gastroenterol. 18(3):245-7. Smith JP. Kramer ST. Demers LM. Effects of gastrin and difluoromethylornithine on growth of human colon cancer. 1993 Mar. Dig Dis Sci. 38(3):520-8. National Cancer Institute Smith JP. Yelamarty RV. Kramer ST. Cheung JY. Effects of cholecystokinin on cytosolic calcium in pancreatic duct segments and ductal cells. 1993 Jun. Am J Physiol. 264(6 Pt 1):G1177-83. National Cancer Institute National Heart, Lung, and Blood Institute Smith JP. Rickabaugh CA. McLaughlin PJ. Zagon IS. Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. 1993 Jul. Am J Physiol. 265(1 Pt 1):G149-55. National Cancer Institute Heald EB. Kramer ST. Smith JP. Trophic effects of unsulfated cholecystokinin on mouse pancreas and human pancreatic cancer. 1992. Pancreas. 7(5):530-5. Smith JP. Kramer S. Bagheri S. Effects of pancreastatin (24-49) on growth of normal pancreas and pancreatic cancer. 1991 Sep. Pancreas. 6(5):551-7. National Cancer Institute Smith JP. Kramer ST. Cheung JY. Effects of cholecystokinin on cytosolic calcium in human pancreatic cancer cells. 1991 Oct 29. Regul Pept. 36(2):299-310. National Cancer Institute National Heart, Lung, and Blood Institute McGarrity TJ. Peiffer LP. Kramer ST. Smith JP. Effects of fat and fiber on human colon cancer xenografted to athymic nude mice. 1991 Nov. Dig Dis Sci. 36(11):1606-10. National Cancer Institute Smith JP. Kramer ST. Solomon TE. CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium. 1991 Feb 26. Regul Pept. 32(3):341-9. National Cancer Institute Smith JP. Solomon TE. Bagheri S. Kramer S. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. 1990 Nov. Dig Dis Sci. 35(11):1377-84. National Cancer Institute National Institute of Diabetes and Digestive and Kidney Diseases Smith JP. Burns TW. Leigh CC. Diabetes mellitus and lipoatrophy. 1990 May. South Med J. 83(5):573-6. Smith JP. Kramer S. Bagheri S. Effects of a high-fat diet and L364,718 on growth of human pancreas cancer. 1990 Jun. Dig Dis Sci. 35(6):726-32. National Cancer Institute Smith JP. Wood JG. Solomon TE. Elevated gastrin levels in patients with colon cancer or adenomatous polyps. 1989 Feb. Dig Dis Sci. 34(2):171-4. Smith JP. Solomon TE. Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. 1988 Dec. Gastroenterology. 95(6):1541-8. Smith JP. Drug overdose: changing concepts for modern drugs. 1986 Oct. South Med J. 79(10):1230-3. Smith JP. Walls JT. Muscato MS. McCord ES. Worth ER. Curtis JJ. Silver D. Extracorporeal circulation in a patient with heparin-induced thrombocytopenia. 1985 Mar. Anesthesiology. 62(3):363-5. Smith JP. Everett ED. Unilateral hypertrophic osteoarthropathy. A clue to aortoenteric fistula. 1983 Jun. Mo Med. 80(6):304-5, 308.